Now that Evolus Inc’s volume has hit 0.46 million, investors get a glimpse of its size.

Evolus Inc (NASDAQ: EOLS) kicked off on Friday, up 1.26% from the previous trading day, before settling in for the closing price of $9.56. Over the past 52 weeks, EOLS has traded in a range of $8.67-$17.82.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has jumped its sales by 51.00% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 23.26%. With a float of $56.92 million, this company’s outstanding shares have now reached $64.45 million.

In an organization with 332 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 67.73%, operating margin of -14.2%, and the pretax margin is -20.19%.

Evolus Inc (EOLS) Insider Updates

Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Evolus Inc is 11.72%, while institutional ownership is 84.45%. The most recent insider transaction that took place on May 12 ’25, was worth 33,397. In this transaction an insider of this company sold 3,385 shares at a rate of $9.87, taking the stock ownership to the 359,082 shares. Before that another transaction happened on May 13 ’25, when Company’s Chief Financial Officer sold 6,494 for $10.02, making the entire transaction worth $65,070. This insider now owns 167,089 shares in total.

Evolus Inc (EOLS) Performance Highlights and Predictions

According to the Wall Street analysts, stocks earnings will be around 23.26% per share during the next fiscal year.

Evolus Inc (NASDAQ: EOLS) Trading Performance Indicators

Take a look at Evolus Inc’s (EOLS) current performance indicators. Last quarter, stock had a quick ratio of 2.16. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.27.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.89, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach 0.57 in one year’s time.

Technical Analysis of Evolus Inc (EOLS)

Let’s dig in a bit further. During the last 5-days, its volume was 0.76 million. That was inferior than the volume of 0.9 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 17.58%. Additionally, its Average True Range was 0.60.

During the past 100 days, Evolus Inc’s (EOLS) raw stochastic average was set at 11.95%, which indicates a significant increase from 10.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.74% in the past 14 days, which was lower than the 72.74% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $11.16, while its 200-day Moving Average is $13.35. However, in the short run, Evolus Inc’s stock first resistance to watch stands at $9.78. Second resistance stands at $9.87. The third major resistance level sits at $10.04. If the price goes on to break the first support level at $9.51, it is likely to go to the next support level at $9.34. Assuming the price breaks the second support level, the third support level stands at $9.25.

Evolus Inc (NASDAQ: EOLS) Key Stats

The company with the Market Capitalisation of 624.12 million has total of 64,476K Shares Outstanding. Its annual sales at the moment are 266,270 K in contrast with the sum of -50,420 K annual income. Company’s last quarter sales were recorded 68,520 K and last quarter income was -18,890 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.